Friday, October 23, 2026

Marc ZERBOLA CHALLANDE

497 POSTS
Marc has been involved in the Stock Market Media Industry for the last +5 years. After obtaining a college degree in engineering in France, he moved to Canada, where he created Money,eh?, a personal finance website.

Exclusive articles:

APRE vs. KPTI: Which Stock is the Best Choice? 

Aprea Therapeutics, Inc. (NASDAQ: APRE) and Karyopharm Therapeutics Inc. (NASDAQ: KPTI) are both clinical-stage biopharmaceutical companies specializing in oncology, each with unique therapeutic approaches...

Stocks to Watch Today on 12/19

Dollar Tree's Leadership Shake-Up Dollar Tree is undergoing a major leadership shift as the company announced that Executive Chairman Richard Dreiling would temporarily take on...

6 Biotech Companies to Watch

The biotechnology sector is home to some of the most innovative companies working to develop treatments for cancer, rare diseases, and other complex medical...

A Closer Look at Aprea Therapeutics

Aprea Therapeutics, Inc. (Nasdaq: APRE), is not just another biotechnology company; it is a pioneer in precision oncology, driven by an unyielding commitment to...

Top 6 Performant Biotech Stocks to Invest in

The biotechnology sector continues to thrive with innovative companies making significant strides in medical technology and pharmaceuticals. Below is an in-depth look at six...

Breaking

AI’s $466 Billion Borrowing Boom Meets Earnings Season

The AI trade is facing a financing test. Companies...

Sekur’s Multilingual Growth Bet and the Earnings Upside

Sekur’s two language launches could open a larger opportunity...

 Sekur’s Multilingual Growth Bet: Why a Few Hundred Customers Could Matter 

 Sekur’s international expansion is entering a more concrete phase. Portuguese...

SpaceX and the chip stock selloff

SpaceX poured $15.8 billion into its AI division in...
spot_img